,,iv  #aaf? ,,congress  #b;d ,session   
,h4 ,,res4 #ihi  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,june #a1 #bjbj,mr4   
,s*iff 7= himself1 ,mrs4 ,c>olyn ,b4    
,maloney ( ,new ,york1 ,ms4             
,ocasio-,cortez1 ,mr4 ,pappas1 ,mr4     
,quigley1 ,ms4 ,lee ( ,cali=nia1 ,ms4   
,haal&1 & ,ms4 ,cl>k ( ,massa*usetts7   
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,en]gy &      
,comm]ce  ,,resolution  ,express+ ! s5se
 ( ! ,h\se ( ,repres5tatives t blood    
donation policies 9 ! ,unit$ ,/ates %\ld
 be equitable & bas$ on sci5ce4  ,:]eas1
 9 #aihc1 ! ,food & ,drug ,adm9i/ration 
7,,fda71 an ag5cy "u ! ,dep>tm5t (      
,heal? & ,human ,s]vices 7,,hhs71       
prohibit$ ! donation ( blood by any man 
:o has _h sex ) ano!r man 7,,msm7 at any
 "t s9ce #aigg2 ,:]eas1 9 ,decemb]      
#bjae1 bas$ on recomm5dations f ! ,,hhs 
,advisory ,committee on ,blood & ,tissue
 ,safety & ,availability1 ! ,,fda       
promulgat$ revis$ regulations to all[ an
 ,,msm to donate blood only if he has n 

be5 sexually active = ! pa/ #ab mon?s2  
,:]eas despite ^! /eps1 a d\ble /&>d    
rema9$ z ! revis$ policy cont9u$ to     
treat gay & bisexual m5 diff]5tly f     
o!rs2 ,:]eas1 on ,april #b1 #bjbj1 !    
,,fda issu$ guidance = imm$iate         
implem5tation to address ! urg5t &      
imm$iate ne$ = blood & blood compon5ts2 
,:]eas ! ,,fda has *ang$ ! recomm5d$    
def]ral p]iod = ,,msm donors f #ab mon?s
 to #c mon?s2 ,:]eas a #c-mon? def]ral  
policy = gay & bisexual m5 to donate    
blood rema9s ov]ly /r+5t giv5 !         
sci5tific evid5ce1 advanc$ te/+ me?ods1 
& ! safety & quality control measures 9 
place )9 ! diff]5t ,,fda-qualifi$ blood 
donat+ c5t]s2 ,:]eas ! ,williams        
,in/itute ( ! ,univ]sity ( ,cali=nia at 
,los ,angeles ,s*ool ( ,law e/imates t1 
bas$ on ! population ( eligible & likely
 donors among ! ,,msm community1 lift+ !
 ,f$]al lifetime def]ral policy on blood
 donation by an ,,msm c\ld result 9 z _m
 z #d1bjj1jjj newly eligible male       
donors1 ( :i* #cfj1fjj w\ld likely      

donate & g5]ate #fae1cjj additional p9ts
 ( blood2 ,:]eas ! increas$ uptake (    
pre-exposure prophylaxis 7,pr,e,p71 :i* 
r$uces ! likelihood t an ,,hiv-negative 
individual w acquire ,,hiv1 has all[$ _m
 m gay & bisexual m5 to be aw>e ( _!    
,,hiv-negative /atus & take /eps to     
effectively elim9ate _! p]sonal risk (  
,,hiv transmission2 ,:]eas m ?an #d1jjj 
blood drives across ! ,unit$ ,/ates h   
be5 cancel$ due to ! ,,covid-#ai p&emic1
 result+ 9 approximately #acj1jjj few]  
donations2 ,:]eas ma9ta9+ an adequate   
blood supply is vital to public heal?2  
,:]eas ! ,am]ican ,r$ ,cross e/imates t 
e #b seconds1 someone 9 ! ,unit$ ,/ates 
ne$s blood2 ,:]eas ! ,am]ican ,m$ical   
,association has /at$ t ! e?ical ideal =
 public policy 9 ?is area %\ld be to    
transition away f policy t def]s        
categories ( p]sons bas$ on attribut+ to
 all memb]s risks associat$ ) a         
population & t[>d policy t def]s        
individual donors on gr\nds (           
evid5ce-bas$ risk assessm5t2 ,:]eas     

,congress direct$ ! ,secret>y ( ,,hhs to
 c>ry out an initiative to improve      
aw>5ess ( ! importance & safety ( blood 
donation & ! cont9u$ ne$ = blood        
donations dur+ ! ,,covid-#ai public     
heal? em]g5cy1 ?r\gh passage ( ! ,,c>es 
,act2 ,:]eas num]\s ,f$]al (ficials1    
includ+ ,surgeon ,g5]al ,dr4 ,j]ome     
,adams & ! ,,hhs ,assi/ant ,secret>y =  
,heal? ,dr4 ,brett ,giroir1 h publicly  
enc\rag$ p to donate blood dur+ !       
,,covid-#ai p&emic2 ,:]eas p :o h fully 
recov]$ f ,,covid-#ai = at lea/ #b weeks
 are enc\rag$ to consid] donat+         
convalesc5t plasma1 :i* conta9s         
antibodies aga9/ ! virus2 ,:]eas        
convalesc5t plasma is be+ evaluat$ z    
treatm5t = pati5ts ) s]i\s or imm$iately
 life-?reat5+ ,,covid-#ai infections1 or
 ^? judg$ by a heal? c>e provid] to be  
at high risk ( progression to sev]e or  
life-?reat5+ disease2 & ,:]eas ! ,,fda  
is 9 ! process ( aga9 reevaluat+ &      
consid]+ updat+ its blood donor def]ral 
policies z new sci5tific in=mation      

becomes available1 includ+ ! feasibility
 ( mov+ f ! exi/+ id5tity-bas$ def]rals 
relat$ to gr\p risk behaviors to        
alt]nate def]ral options1 su* z ! use ( 
individual risk assessm5ts3 ,n[1 !re=e1 
be x ,t x is ! s5se ( ! ,h\se (         
,repres5tatives t policies gov]n+ blood 
& blood product donation 9 ! ,unit$     
,/ates %\ld-- 7#a7 be gr\nd$ 9 sci5ce2  
7#b7 m9imize def]ral p]iods2  7#c7 be   
bas$ on individual risk factors2  7#d7 n
 unfairly s+le out any gr\p (           
individuals2 &  7#e7 all[ donations by  
all ^? :o c safely d s4